These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15498386)

  • 21. Hope in the modern plague.
    Nat Med; 2001 May; 7(5):511. PubMed ID: 11329026
    [No Abstract]   [Full Text] [Related]  

  • 22. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression.
    Ogunro PS; Ogungbamigbe TO; Elemie PO; Egbewale BE; Adewole TA
    Niger Postgrad Med J; 2006 Mar; 13(1):1-5. PubMed ID: 16633369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
    Betts MR; Gray CM; Cox JH; Ferrari G
    Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on T cell subsets in HIV/AIDS patients].
    Li HY; Cao ZH; Ji YX; Wu H; Chen XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):284-6. PubMed ID: 19105345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune surveillance and AIDS progression.
    Zinkernagel R; Klenerman P
    Curr Biol; 1997 Jul; 7(7):R403-5. PubMed ID: 9210384
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
    Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection.
    Wang X; Zhang Z; Zhang S; Fu J; Yao J; Jiao Y; Wu H; Wang FS
    Eur J Immunol; 2008 Nov; 38(11):3226-36. PubMed ID: 18924219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of IL-7 with disease progression in Chinese HIV-1 seropositive individuals.
    Wang Q; Shang H; Wang YN; Jiang YJ; Liu J; Zhang ZN
    Chin Med J (Engl); 2006 Feb; 119(4):288-93. PubMed ID: 16537023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
    Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV and AIDS.
    Laman JD
    Science; 1993 Jun; 260(5115):1707-8. PubMed ID: 8511573
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between psychological distress and T lymphocyte in HIV/AIDS patients].
    Lu SH; Tang XP; Deng XL; Chen WL; Hu RX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):23-5. PubMed ID: 19799009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of cytotoxic T lymphocytes specific for autologous Epstein-Barr virus in HIV-infected patients: the feasibility study of EBV-specific immunotherapy for patients with EBV-associated lymphoma.
    Hansasuta P; Incomserb P; Buranapraditkun S; Bhattarakosol P
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S146-51. PubMed ID: 16083179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
    Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
    Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Linking Nef with the immunological and virological determinants of AIDS].
    Gómez-Icazbalceta G; Larralde C
    Rev Invest Clin; 2009; 61(3):243-51. PubMed ID: 19736813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS: the evolving story.
    Phillips RE; Oxenius A; Price DA; Bangham CR
    Trends Microbiol; 2000 Apr; 8(4):147-8. PubMed ID: 10754566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.